Tralokinumab did not demonstrate oral corticosteroid-sparing effects in severe asthma

RECOMMENDED

Asthma

Consequences of long-term oral corticosteroid therapy and its side-effects in severe asthma in adults: a focused review of the impact data in the literature

Eur Respir J.

Volmer T, Effenberger T, Trautner C, Buhl R

doi: 10.1183/13993003.

RECOMMENDED

Asthma

Effect of fixed-dose subcutaneous reslizumab on asthma exacerbations in patients with severe uncontrolled asthma and corticosteroid sparing in patients with oral corticosteroid-dependent asthma: results from two phase 3, randomised, double-blind, placebo-controlled trials

★ 3 Recommended by Dr Martin Frey, Faculty Member

★ 3 Recommended by Dr Marcus Hesse, Faculty Member

Lancet Respir Med.

Bernstein JA, Virchow JC, Murphy K, Maspero JF, Jacobs J, Adir Y, Humbert M, Castro M, Marsteller DA, McElhattan J, Hickey L, Garin M, Vanlandingham R, Brusselle G

doi: 10.1016/S2213-2600(19)30372-8.

Asthma

Oral Glucocorticoid-Sparing Effect of Benralizumab in Severe Asthma

N Engl J Med.

Nair P, Wenzel S, Rabe KF, Bourdin A, Lugogo NL, Kuna P, Barker P, Sproule S, Ponnarambil S, Goldman M; ZONDA Trial Investigators

doi: 10.1056/

COMMENTED

Consequences of long-term OCS therapy and its side effects in severe asthma in adults - A focused review of the impact data in the literature

Eur Respir J.

Volmer T, Effenberger T, Trautner C, Buhl R

doi: 10.1183/

COMMENTED

Effects of Systemic Corticosteroids on Blood Eosinophil Counts in Asthma: Real-World Data

J Asthma.

Ortega H, Llanos JP, Lafeuille MH, Duh MS, Germain G, Lejeune D, Sama S, Bell C, Hahn B

doi: 10.1080/

RECOMMENDED

Asthma

Chronic oral corticosteroids use and persistent eosinophilia in severe asthmatics from the Belgian severe asthma registry

★ 2 Recommended by Dr Martin Frey, Faculty Member

Respir Res

Graff S, Vanwynsberghe S, Brusselle G, Hanon S, Sohy C, Dupont LJ, Peche R, Michils A, Pilette C, Joos G, Louis RE, Schleich FN

doi: 10.1186/s12931-020-01460-7

RECOMMENDED

Asthma

Chronic oral corticosteroids use and persistent eosinophilia in severe asthmatics from the Belgian severe asthma registry

Respir Res.

Graff S, Vanwynsberghe S, Brusselle G, Hanon S, Sohy C, Dupont LJ, Peche R, Michils A, Pilette C, Joos G, Louis RE, Schleich FN

doi: 10.1186/s12931-020-01460-7.

Asthma

Tralokinumab for severe, uncontrolled asthma (STRATOS 1 and STRATOS 2): two randomised, double-blind, placebo-controlled, phase 3 clinical trials

Lancet Respir Med.

Panettieri R, Sjöbring U, Péterffy AM, Wessman P, Bowen K, Piper E, Colice G, Brightling Ch

doi: 10.1016/

RECOMMENDED

Asthma

Real-World Reductions in Oral Corticosteroid Use in the USA Following Mepolizumab Therapy for Severe Asthma

★ 2 Recommended by Dr Martin Frey, Faculty Member

★ 2 Recommended by Dr Marcus Hesse, Faculty Member

J Asthma Allergy

Silver J, Bogart M, Packnett E, Wu J, McMorrow D, Hahn B

doi: 10.2147/JAA.S275944

Related content

Consequences of long-term oral corticosteroid therapy and its side-effects in severe asthma in adults: a focused review of the impact data in the literature

Effect of fixed-dose subcutaneous reslizumab on asthma exacerbations in patients with severe uncontrolled asthma and corticosteroid sparing in patients with oral corticosteroid-dependent asthma: results from two phase 3, randomised, double-blind, placebo-controlled trials

Oral Glucocorticoid-Sparing Effect of Benralizumab in Severe Asthma

Consequences of long-term OCS therapy and its side effects in severe asthma in adults - A focused review of the impact data in the literature

Effects of Systemic Corticosteroids on Blood Eosinophil Counts in Asthma: Real-World Data

Chronic oral corticosteroids use and persistent eosinophilia in severe asthmatics from the Belgian severe asthma registry

Chronic oral corticosteroids use and persistent eosinophilia in severe asthmatics from the Belgian severe asthma registry

Tralokinumab for severe, uncontrolled asthma (STRATOS 1 and STRATOS 2): two randomised, double-blind, placebo-controlled, phase 3 clinical trials

Real-World Reductions in Oral Corticosteroid Use in the USA Following Mepolizumab Therapy for Severe Asthma